V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20121799 | 20087388 | 1.71 | 78.9 | null | 2018-03-22 | 2018-03-22 | HEP HR Hepatoblastoma guide cisp | 01 | N | COSMIC TRIAL | 101838727 |
| 20121827 | 20087389 | 1.81 | 79.6 | 03 | null | 2020-12-04 | Irinotecan | 02 | N | PHITT C SIOPEL-3HR | 101766179 |
| 20121990 | 20087390 | 1.84 | 72.1 | 03 | 2015-06-16 | 2015-07-02 | CISPLATIN + TEYSUNO | 02 | N | PACLITAXEL | 101278656 |
| 20122002 | 20087391 | 1.71 | 77.4 | Adjuvant (A) | 2018-10-15 | 2018-10-21 | Carbo F | 01 | N | CAPECITABINE + STREPTOZOCIN | 101771973 |
| 20122040 | 20087392 | 1.68 | 73.4 | Palliative (P) | 2019-06-03 | 2019-06-03 | OXALIPLATIN | 01 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101840454 |
| 20122070 | 20087393 | 1.77 | 75 | 03 | 2017-12-15 | 2018-01-12 | Carboplatin + Pemetrexed | 2 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101572607 |
| 20122132 | 20087394 | 1.62 | 84.5 | null | 2018-05-31 | 2018-06-01 | HEP HR Hepatoblastoma guide cisp | 02 | N | PONATINIB | 101332947 |
| 20122166 | 20087395 | 1.69 | 92 | Adjuvant (A) | 2018-05-30 | 2018-05-31 | ACELARATE Trial | N | N | ACELARATE TRIAL | 100237545 |
| 20122253 | 20087396 | 1.75 | 72 | 03 | 2016-05-17 | 2016-05-17 | PANTHER TRIAL | 02 | N | ARISTOTLE TRIAL | 100911718 |
| 20122304 | 20087397 | 1.71 | 92 | 03 | 2017-08-13 | 2017-08-15 | Everolimus 10mg | 02 | N | TIPIRACIL + TRIFLURIDINE | 101514180 |
| 20122320 | 20087398 | 1.69 | 96.5 | null | 2015-08-30 | 2015-09-26 | PHITT C CDDP-M | N | Y | NEO-AEGIS TRIAL | 100083095 |
| 20122367 | 20087399 | 1.64 | 54.5 | null | 2019-08-09 | 2019-08-09 | ECarboF | 02 | N | GEMCITABINE + PACLITAXEL | 100964969 |
| 20122409 | 20087400 | null | 47.55 | 03 | 2021-11-06 | 2021-11-10 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | Y | CAPE + OXALIPLATIN + TRASTUZUMAB | 100193854 |
| 20122467 | 20087401 | 1.6 | 64.3 | null | 2017-12-14 | 2017-12-23 | CHOP - 21 days | 02 | N | NAB-PACLITAXEL | 101785734 |
| 20122584 | 20087402 | 1.49 | 61.2 | Palliative (P) | 2017-02-01 | 2017-02-01 | Raltitrexed | N | N | EOF | 100795329 |
| 20122622 | 20087403 | 1.78 | 48 | Palliative (P) | 2019-01-07 | 2019-01-15 | FCarboSt | N | N | GEMCARBO | 100674999 |
| 20122627 | 20087404 | null | 88.15 | null | 2018-08-29 | 2018-09-13 | GO2 TRIAL | 02 | Y | OXALIPLATIN + MDG + PANITUMUMAB | 101368805 |
| 20122641 | 20087406 | 1.7 | 50.2 | Palliative (P) | 2018-12-07 | 2018-12-17 | null | 02 | N | AZACITIDINE | 100081690 |
| 20122790 | 20087407 | 1.7 | 81.9 | Palliative (P) | 2019-10-10 | 2019-10-23 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | COSMIC TRIAL | 100285928 |
| 20122862 | 20087408 | 1.78 | 77.4 | Adjuvant (A) | 2019-07-18 | 2019-07-18 | Docetaxel 75mg/m2 (21 day) | 02 | null | EOF | 101168979 |
| 20122938 | 20087409 | 1.77 | 88 | 03 | 2021-05-30 | 2021-05-30 | Capital Trial | 02 | N | ARISTOTLE TRIAL | 100259335 |
| 20123016 | 20087410 | 1.7 | 68.5 | Adjuvant (A) | 2019-08-04 | 2019-08-04 | LENALIDOMIDE | 02 | N | CISPLATIN + PEMETREXED | 101017673 |
| 20123091 | 20087411 | 1.68 | 74.6 | Palliative (P) | 2018-02-12 | 2018-02-13 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | INCA TRIAL | 101195303 |
| 20123094 | 20087412 | 1.7 | 50.7 | 03 | null | 2016-08-27 | null | 99 | N | PHITT C SIOPEL-3HR | 100504816 |
| 20123124 | 20087413 | 1.45 | 64.6 | Palliative (P) | 2017-03-26 | 2017-04-03 | null | 01 | N | ABIRATERONE | 100010387 |
| 20123134 | 20087414 | 1.64 | 81.45 | null | 2017-12-09 | 2017-12-15 | CARBOPLATIN + VINORELBINE | N | N | NEO-AEGIS TRIAL | 101070848 |
| 20123140 | 20087415 | 1.56 | 44 | Adjuvant (A) | 2017-11-28 | 2017-12-19 | Hydroxycarbamide | 02 | Y | IRINOTECAN | 101760433 |
| 20123315 | 20087416 | 1.6 | 84.45 | 03 | 2018-03-03 | 2018-03-03 | DOXORUBICIN | N | Y | ABIRATERONE | 101147115 |
| 20123338 | 20087417 | 1.54 | 124.9 | null | 2018-06-05 | 2018-07-07 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | EPIRUBICIN + OXALIPLATIN + RALTITREXED | 100455057 |
| 20123388 | 20087418 | 0 | 0 | null | 2017-06-23 | 2017-07-03 | MITOMYCIN | 01 | N | CARBOPLATIN + FLUOROURACIL | 100029959 |
| 20123395 | 20087419 | 1.67 | 67.5 | null | 2017-12-12 | 2018-01-02 | Capital Trial | N | N | LETROZOLE + PALBOCICLIB | 100707225 |
| 20123432 | 20087420 | 1.72 | 63.4 | Adjuvant (A) | 2019-04-02 | 2019-04-03 | PLATO Trials | 02 | N | PLATO TRIAL | 100581735 |
| 20123468 | 20087421 | 1.7 | 142 | Adjuvant (A) | 2019-06-19 | 2019-06-20 | Capecitabine+Cisplatin+Streptozocin | 02 | N | OXALIPLATIN | 100203840 |
| 20123528 | 20087423 | 1.8 | 78.5 | 03 | null | 2018-07-08 | null | null | N | EVEROLIMUS | 101636343 |
| 20123554 | 20087424 | 1.78 | 77 | Palliative (P) | null | 2021-08-03 | null | null | N | CAPITAL TRIAL | 101836806 |
| 20123610 | 20087425 | 1.7 | 62 | 03 | 2019-08-11 | 2019-08-11 | Capecitabine + Streptozocin | 02 | N | DOCETAXEL | 100129505 |
| 20123611 | 20087426 | 1.62 | 108.9 | null | 2018-01-03 | 2018-01-03 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | GEMCITABINE + PACLITAXEL | 101123141 |
| 20123720 | 20087427 | 0 | 0 | Palliative (P) | 2019-10-13 | 2019-10-13 | PRIMUS 002 TRIAL | 02 | N | PACIFICO TRIAL | 100302272 |
| 20123749 | 20087428 | 1.63 | 82.2 | Palliative (P) | 2020-05-06 | 2020-05-08 | CHOP - 21 days | null | null | EOF | 100014955 |
| 20123772 | 20087429 | 1.79 | 81 | Palliative (P) | 2022-01-14 | 2022-01-30 | Cisplatin + Vinorelbine (PO) | 02 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100714471 |
| 20123799 | 20087430 | 1.75 | 67.6 | null | 2018-10-06 | 2018-10-22 | Paclitaxel 7 day | 02 | N | PEMBROLIZUMAB | 100400934 |
| 20123898 | 20087431 | 1.78 | 76.4 | Palliative (P) | 2017-08-21 | 2017-08-26 | Hydroxycarbamide | N | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100322208 |
| 20123916 | 20087432 | 1.78 | 100 | Adjuvant (A) | 2015-01-08 | 2015-01-08 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | SCOPE2 TRIAL | 100148757 |
| 20123917 | 20087433 | 1.55 | 68 | Palliative (P) | 2016-12-17 | 2017-01-01 | FEC | 01 | N | RITUXIMAB | 100494997 |
| 20123953 | 20087435 | 1.82 | 83.4 | Palliative (P) | 2018-10-17 | 2018-10-17 | Docetaxel | null | N | BORTEZOMIB + MELPHALAN | 100074657 |
| 20124005 | 20087436 | 1.6 | 64 | 03 | 2018-02-25 | 2018-03-18 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101570061 |
| 20124035 | 20087437 | 1.55 | 61.45 | 03 | null | 2018-10-01 | ESPAC-4 TRIAL | 01 | N | ECARBOX | 100810211 |
| 20124045 | 20087438 | 1.58 | 140.2 | Palliative (P) | 2018-04-30 | 2018-05-30 | Panitumumab | N | N | ABIRATERONE | 100831046 |
| 20124067 | 20087439 | 1.73 | 71.2 | 03 | null | 2018-04-11 | null | N | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100017932 |
| 20124087 | 20087440 | 1.75 | 67.5 | 03 | 2018-05-01 | 2018-05-05 | Capecitabine + Streptozocin | Y | N | PACLITAXEL + RAMUCIRUMAB | 100508317 |